{"version":"1.0","type":"link","title":"Synergistic Antitumor Activity of Combination Therapy with a MET TKI Vabametkib and a Third-Generation EGFR TKI Lazertinib in MET-Amplified EGFR-Mutant NSCLC.","author_name":"Kim DK 외","author_url":"https://prs-insight.online/author/Kim%20DK","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/95099","thumbnail_width":1200,"thumbnail_height":630}